Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 8/2011

01-08-2011 | Letter to the Editors

Genetic variation in caspase-1 as predictor of accelerated progression from mild cognitive impairment to Alzheimer’s disease

Authors: Ana Pozueta, José Luis Vázquez-Higuera, Pascual Sánchez-Juan, Eloy Rodríguez-Rodríguez, Coro Sánchez-Quintana, Ignacio Mateo, José Berciano, Onofre Combarros

Published in: Journal of Neurology | Issue 8/2011

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
Barabash A, Marcos A, Ancín I, Vázquez-Alvarez B, de Ugarte C, Gil P, Fernández C, Encinas M, López-Ibor JJ, Cabranes JA (2009) APOE, ACT and CHRNA7 genes in the conversión from amnestic mild cognitive impairment to Alzheimer’s disease. Neurobiol Aging 30:1254–1264PubMedCrossRef
2.
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR Jr, Weiner MW, Jagust WJ, Alzheimer′s Disease Neuroimaging Initiative (2010) Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75:230–238PubMedCrossRef
3.
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985–1992PubMedCrossRef
4.
Reitz C, Mayeux R (2010) Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J Alzheimers Dis 19:229–251PubMed
5.
Trompet S, de Craen AJM, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Jukema JW, Westendorp RGJ, PROSPER Group (2008) Genetic variation in the interleukin-Iβ-converting enzyme associates with cognitive function. The PROSPER study. Brain 131:1069–1077PubMedCrossRef
6.
Vázquez-Higuera JL, Rodríguez-Rodríguez E, Sánchez-Juan P, Mateo I, Pozueta A, Martínez-García A, Frank A, Valdivieso F, Berciano J, Bullido MJ, Combarros O (2010) Caspase-1 genetic variation is not associated with Alzheimer’s disease risk. BMC Med Genet 11:32PubMedCrossRef
Metadata
Title
Genetic variation in caspase-1 as predictor of accelerated progression from mild cognitive impairment to Alzheimer’s disease
Authors
Ana Pozueta
José Luis Vázquez-Higuera
Pascual Sánchez-Juan
Eloy Rodríguez-Rodríguez
Coro Sánchez-Quintana
Ignacio Mateo
José Berciano
Onofre Combarros
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 8/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-5935-y

Other articles of this Issue 8/2011

Journal of Neurology 8/2011 Go to the issue

Original Communication

A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes

Letter to the Editors

Hyoid bone-related focal carotid vasculopathy

Letter to the Editors

Delayed hyperbaric oxygen treatment after acute carbon monoxide poisoning

Original Communication

The health-related, social, and economic consequences of parkinsonism: a controlled national study

Original Communication

A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A)

Letter to the Editors

Posterior reversible encephalopathy syndrome following disulfiram intoxication